# Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO

> **NCT03036995** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 80 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Apremilast
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03036995
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-20
- **Primary completion:** 2018-11-08
- **Final completion:** 2019-11-25
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03036995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03036995, "Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03036995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*